Iovance BiotherapeuticsIOVA
那斯達克 · USD
2.25
-0.01
(-0.44%)
收盤 12/12 04:59 (UTC+8)
盤後
2.24
2.24
(-0.44%)
12/12 04:59 (UTC+8)
Iovance BiotherapeuticsIOVA
2.25
-0.01
(-0.44%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.01
- 0.31
- 0.59
- 0.74
- 0.49
- 0.60
- 0.67
- -
- 97.06
- 2.77
- 48.34
- 4250.49
- 88.24
- 25.85
- -33.07
- 21.55
- 12.52
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 67,455 | 59,952 | 49,324 | 73,694 | 58,555 | 31,106 | 715 | 482 | 469 | 238 |
營業成本 | 23,668 | 56,664 | 49,741 | 68,536 | 39,823 | 31,368 | 7,261 | 4,365 | 4,340 | 2,050 |
營業毛利 | 43,787 | 3,288 | -417 | 5,158 | 18,732 | -262 | -6,546 | -3,883 | -3,871 | -1,812 |
營業費用 | 138,688 | 117,062 | - | 91,734 | - | - | 111,176 | 117,373 | 114,490 | 108,274 |
研發費用 | 72,825 | 79,363 | 76,879 | 77,115 | 68,245 | 62,084 | 79,783 | 87,470 | 87,526 | 86,347 |
推銷及管理費用 | 34,298 | 37,699 | 43,925 | 43,069 | 39,553 | 39,568 | 31,393 | 29,903 | 26,964 | 21,927 |
非經常性項目費用 | 5,143 | - | - | - | - | - | - | - | - | - |
其他營業費用 | 26,422 | - | - | -28,450 | - | - | - | - | - | - |
營業利益 | -94,901 | -113,774 | -121,221 | -86,576 | -89,066 | -101,914 | -117,722 | -121,256 | -118,361 | -110,086 |
其他收入及費用 | 1,243 | 4,104 | 3,220 | 9,575 | 4,005 | 3,355 | 3,338 | 3,118 | 3,358 | 3,081 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -93,658 | -109,670 | -118,001 | -77,001 | -85,061 | -98,559 | -114,384 | -118,138 | -115,003 | -107,005 |
所得稅 | -2,405 | 1,988 | -1,838 | 1,558 | -1,520 | -1,458 | -1,408 | -1,759 | -1,243 | -477 |
稅後純益 | -91,253 | -111,658 | -116,163 | -78,559 | -83,541 | -97,101 | -112,976 | -116,379 | -113,760 | -106,528 |
基本每股稅後盈餘(元) | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | - | -0.46 | -0.47 |
稀釋每股稅後盈餘(元) | -0.25 | -0.33 | -0.36 | -0.25 | -0.27 | -0.34 | -0.42 | -0.45 | -0.46 | -0.48 |
基本平均股數(千股) | 364037.00 | 334511.00 | 322868.00 | 304890.00 | 303269.00 | 284817.00 | 266220.00 | - | 245817.00 | 224481.00 |
稀釋平均股數(千股) | 364037.00 | 334511.00 | 322868.00 | 304890.00 | 303269.00 | 284817.00 | 266220.00 | - | 245817.00 | 224481.00 |
還原基本每股稅後盈餘(元) | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | - | -0.46 | -0.47 |
還原稀釋每股稅後盈餘(元) | -0.25 | -0.33 | -0.36 | -0.25 | -0.27 | -0.34 | -0.42 | -0.45 | -0.46 | -0.48 |
還原基本平均股數(千股) | 364,037 | 334,511 | 322,868 | 304,890 | 303,269 | 284,817 | 266,220 | - | 245,817 | 224,481 |
還原稀釋平均股數(千股) | 364,037 | 334,511 | 322,868 | 304,890 | 303,269 | 284,817 | 266,220 | - | 245,817 | 224,481 |
EBITDA(千元) | -83,692 | -99,735 | -109,082 | -67,074 | -76,568 | -90,194 | -106,812 | -110,151 | -106,151 | -99,041 |